Michael Barnes, JD recently made an appearance on Fox Business Live, where he discussed conflicting messages about the impact of the U.S. drug abuse crisis on corporate profits. Mr. Barnes then analyzed drug pricing bills in Congress and how they could affect Americans’ access to new medicines for conditions like Alzheimer’s and cancer. The original […]
On Thursday, October 24, the Senate Finance Committee held a full committee hearing on the topic of substance abuse in the United States. Among the witnesses was the Surgeon General of the United States, Jerome M. Adams, MD, MPH. Dr. Adams detailed the current approach of the Department of Health and Human Services (HHS), highlighted […]
An article published yesterday by Pain News Network’s Pat Anson tells the story of yet another physician who has faced threats from the Department of Justice (DOJ) due to the use of opioids within his practice. Dr. Roger Kasendorf, a physician from Southern California, paid a settlement of $125,000 rather than defend against allegations of […]
On October 17, 2019, Filter published an article titled “Why Opioid Pharma Hatred Is Overblown and Harmful,” which featured an interview with Michael C. Barnes, JD. The article’s author, Alison Knopf, shed light on the nuances of the overdose crisis that are often overlooked in mainstream media narratives, with particular focus on the vilification of […]
Earlier this week, Shruti Kulkarni, JD presented at HealthyWomen’s Chronic Pain Summit. Ms. Kulkarni’s presentation, “Gender Differences in Pain and Substance Use Disorders: Eliminate Discrimination, Improve Treatment, and Save Lives,” provided an overview of gender differences in the effects of medication and treatment for substance use disorders (SUDs). The presentation explained how pharmaceutical research and […]